Barcode technology in yeast: Application to pharmacogenomics

FEMS Yeast Research

Volumn 10, Issue 8, 2010, Pages 1083-1089

  Delneri, Daniela ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Barcode technology; Genome profiling; TAG arrays; Yeast deletion collection

Indexed keywords

ALENDRONIC ACID; ATORVASTATIN; BENOMYL; CHITOSAN; CISPLATIN; FLUCONAZOLE; FLUOROURACIL; HIGH MOBILITY GROUP B1 PROTEIN; IBANDRONIC ACID; METHOTREXATE; MEVINOLIN; MOLSIDOMINE; MORPHOLINE; RAPAMYCIN; RISEDRONIC ACID; TUNICAMYCIN; WORTMANNIN;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; CELL SURVIVAL; CHROMATIN; DNA BARCODING; DNA REPLICATION; DRUG TARGETING; EXOSOME; GENE DELETION; GENE DISRUPTION; GENE SEQUENCE; HAPLOIDY; HETEROZYGOTE; MICROTUBULE; NONHUMAN; OSTEOLYSIS; OSTEOPOROSIS; PHARMACOGENOMICS; PROTEIN FOLDING; REVIEW; RNA PROCESSING; SACCHAROMYCES CEREVISIAE;

HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MUTAGENESIS, INSERTIONAL; PHARMACOGENETICS; SACCHAROMYCES CEREVISIAE; SELECTION, GENETIC; STAINING AND LABELING;

SACCHAROMYCES CEREVISIAE;

EID: 78349286311     PISSN: 15671356     EISSN: 15671364     Source Type: Journal    
DOI: 10.1111/j.1567-1364.2010.00676.x     Document Type: Review

References (52)

1. Barrientos A (2003) Yeast models of human mitochondrial diseases. IUBMB Life 55: 83-95.
2. Birrell GW, Giaever G, Chu AM, Davis RW & Brown JM (2001) A genome-wide screen in Saccharomyces cerevisiae for genes affecting UV radiation sensitivity. P Natl Acad Sci USA 98: 12608-12613.
3. Bivi N, Romanello M, Harrison R et al. (2009) Identification of secondary targets of N-containing bisphosphonates in mammalian cells via parallel competition analysis of the barcoded yeast deletion collection. Genome Biol 10: R93.
4. Blanquet S, Marol-Bonnin S, Beyssac E, Pompon D, Renaud M & Alric M (2001) The 'biodrug' concept: an innovative approach to therapy. Trends Biotechnol 19: 393-400.
5. Chan TF, Carvalho J, Riles L & Zheng XF (2000) A chemical genomics approach toward understanding the global functions of the target of rapamycin protein (TOR). P Natl Acad Sci USA 97: 13227-13232.
6. Clézardin P, Ebetino FH & Fournier PG (2005) Bisphosphonates and cancer-induced bone disease: beyond their antiresorptive activity. Cancer Res 65: 4971-4974.
7. Cook EH & Scherer SW (2008) Copy-number variations associated with neuropsychiatric conditions. Nature 455: 919-923.
8. Foury F (1997) Human genetic diseases - a cross-talk between man and yeast. Gene 195: 1-10.
9. Foury F & Kucej M (2002) Yeast mitochondrial biogenesis: a model system for humans? Curr Opin Chem Biol 6: 106-111.
10. Delneri D, Hoyle DC, Gkargkas K et al. (2008) Identification and characterization of high-flux-control genes of yeast through competition analyses in continuous cultures. Nat Genet 40: 113-117.
11. DeRisi JL, Iyer VR & Brown PO (1997) Exploring the metabolic and genetic control of gene expression on a genomic scale. Science 278: 680-686.
12. Deutschbauer AM, Jaramillo DF, Proctor M, Kumm J, Hillenmeyer ME, Davis RW, Nislow C & Giaever G (2005) Mechanisms of haploinsufficiency revealed by genome-wide profiling in yeast. Genetics 169: 1915-1925.
13. Eason RG, Pourmand N, Tongprasit W, Herman Z, Anthony K, Jejelowo O, Davis RW & Stolc V (2004) Characterization of synthetic DNA bar codes in Saccharomyces cerevisiae gene-deletion strains. P Natl Acad Sci USA 101: 11046-11051.
14. Giaever G (2003) A chemical genomics approach to understanding drug action. Trends Pharmacol Sci 24: 444-446.
15. Giaever G, Shoemaker DD, Jones TW, Liang H, Winzeler EA, Astromoff A & Davis RW (1999) Genomic profiling of drug sensitivities via induced haploinsufficiency. Nat Genet 21: 278-283.
16. Giaever G, Chu AM, Ni L et al. (2002) Functional profiling of the Saccharomyces cerevisiae genome. Nature 418: 387-391.
17. Giaever G, Flaherty P, Kumm J, Proctor M, Nislow C, Jaramillo DF, Chu AM, Jordan MI, Arkin AP & Davis RW (2004) Chemogenomic profiling: identifying the functional interactions of small molecules in yeast. P Natl Acad Sci USA 101: 793-798.
18. Goffeau A, Barrell BG, Bussey H et al. (1996) Life with 6000 genes. Science 274: 546-567.
19. Gonzalez E, Kulkarni H, Bolivar H et al. (2005) The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science 307: 1434-1440.
20. Goss KH, Risinger MA, Kordich JJ, Sanz MM, Straughen JE, Slovek LE, Capobianco AJ, German J, Boivin GP & Groden J (2002) Enhanced tumor formation in mice heterozygous for Blm mutation. Science 297: 2051-2053.
21. Hanway D, Chin JK, Xia G, Oshiro G, Winzeler EA & Romesberg FE (2002) Previously uncharacterized genes in the UV- and MMS-induced DNA damage response in yeast. P Natl Acad Sci USA 99: 10605-10610.
22. Hartwell LH, Culotti J & Reid B (1970) Genetic control of the cell-division cycle in yeast, I. Detection of mutants. P Natl Acad Sci USA 66: 352-359.
23. Holland S, Lodwig E, Sideri T, Reader T, Clarke I, Gkargkas K, Hoyle DC, Delneri D, Oliver SG & Avery SV (2007) Application of the comprehensive set of heterozygous yeast deletion mutants to elucidate the molecular basis of cellular chromium toxicity. Genome Biol 8: R268.
24. Kim DU, Hayles J, Kim D et al. (2010) Analysis of a genome-wide set of gene deletions in the fission yeast Schizosaccharomyces pombe. Nat Biotechnol 28: 617-623.
25. Lum PY, Armour CD, Stepaniants SB et al. (2004) Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes. Cell 116: 121-137.
26. McAleer WJ, Buynak EB, Maigetter RZ, Wampler DE, Miller WJ & Hilleman MR (1984) Human hepatitis B vaccine from recombinant yeast. Nature 307: 178-180.
27. Mnaimneh S, Davierwala AP, Haynes J et al. (2004) Exploration of essential gene functions via titratable promoter alleles. Cell 118: 31-44.
28. Oh J, Fung E, Price MN, Dehal PS, Davis RW, Giaever G, Nislow C, Arkin AP & Deutschbauer A (2010) A universal TagModule collection for parallel genetic analysis of microorganisms. Nucleic Acids Res 38: e146.
29. Omara WA, Rash BM, Hayes A, Wickham MS, Oliver SG & Stateva LI (2010) Conditional cell-wall mutants of Saccharomyces cerevisiae as delivery vehicles for therapeutic agents in vivo to the GI tract. J Biotechnol 147: 136-143.
30. Pierce SE, Fung EL, Jaramillo DF, Chu AM, Davis RW, Nislow C & Giaever G (2006) A unique and universal molecular barcode array. Nat Methods 3: 601-603.
31. Redon R, Ishikawa S, Fitch KR et al. (2006) Global variation in copy number in the human genome. Nature 444: 444-454.
32. Russell P & Nurse P (1986) Schizosaccharomyces pombe and Saccharomyces cerevisiae: a look at yeasts divided. Cell 45: 781-782.
33. Schnekenburger M, Talaska G & Puga A (2007) Chromium cross-links histone deacetylase 1-DNA methyltransferase 1 complexes to chromatin, inhibiting histone-remodeling marks critical for transcriptional activation. Mol Cell Biol 27: 7089-7101.
34. Sebat J, Lakshmi B, Malhotra D et al. (2007) Strong association of de novo copy number mutations with autism. Science 316: 445-449.
35. Shoemaker DD, Lashkari DA, Morris D, Mittmann M & Davis RW (1996) Quantitative phenotypic analysis of yeast deletion mutants using a highly parallel molecular bar-coding strategy. Nat Genet 14: 450-456.
36. Smith AM, Heisler LE, Mellor J, Kaper F, Thompson MJ, Chee M, Roth FP, Giaever G & Nislow C (2009) Quantitative phenotyping via deep barcode sequencing. Genome Res 19: 1836-1842.
37. Smith AM, Heisler LE, St Onge RP et al. (2010) Highly-multiplexed barcode sequencing: an efficient method for parallel analysis of pooled samples. Nucleic Acids Res 38: e142.
38. Spring K, Ahangari F, Scott SP, Waring P, Purdie DM, Chen PC, Hourigan K, Ramsay J, McKinnon PJ, Swift M & Lavin MF (2002) Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer. Nat Genet 32: 185-190.
39. St Clair D (2008) Copy number variation and schizophrenia. Schizophrenia Bull 35: 9-12.
40. Steinmetz LM, Scharfe C, Deutschbauer AM et al. (2002) Systematic screen for human disease genes in yeast. Nat Genet 31: 400-404.
41. Thompson K, Rogers MJ, Coxon FP & Crockett JC (2006) Cytosolic entry of bisphosphonate drugs requires acidification of vesicles after fluid-phase endocytosis. Mol Pharmacol 69: 1624-1632.
42. True HL & Lindquist SL (2000) A yeast prion provides a mechanism for genetic variation and phenotypic diversity. Nature 407: 477-483.
43. Uetz P, Giot L, Cagney G et al. (2000) Protein-protein interactions in Saccharomyces cerevisiae. Nature 403: 623-627.
44. Verdijk R, Franke HR, Wolbers FN & Vermes I (2007) Differential effects of bisphosphonates on breast cancer cell lines. Cancer Lett 246: 308-312.
45. Wach A, Brachat A, Pöhlmann R & Philippsen P (1994) New heterologous modules for classical or PCR-based gene disruptions in Saccharomyces cerevisiae. Yeast 10: 1793-1808.
46. Willingham S, Outeiro TF, DeVit MJ, Lindquist SL & Muchowski PJ (2003) Yeast genes that enhance the toxicity of a mutant huntingtin fragment or alpha-synuclein. Science 302: 1769-1772.
47. Winzeler EA, Shoemaker DD, Astromoff A et al. (1999) Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science 285: 901-906.
48. Yan Z, Costanzo M, Heisler LE, Paw J, Kaper F, Andrews BJ, Boone C, Giaever G & Nislow C (2008) Yeast Barcoders: a chemogenomic application of a universal donor-strain collection carrying bar-code identifiers. Nat Methods 5: 719-725.
49. Yang H, Zonder JA & Dou QP (2009) Clinical development of novel proteasome inhibitors for cancer treatment. Expert Opin Inv Drug 18: 957-971.
50. Yu L, Lopez A, Anaflous A et al. (2008) Chemical-genetic profiling of imidazo[1, 2-a]pyridines and -pyrimidines reveals target pathways conserved between yeast and human cells. PLoS Genet 4: e1000284.
51. Zakrzewska A, Boorsma A, Delneri D, Brul S, Oliver SG & Klis FM (2007) Cellular processes and pathways that protect Saccharomyces cerevisiae cells against the plasma membrane-perturbing compound chitosan. Eukaryot Cell 6: 600-608.
52. Zewail A, Xie MW, Xing Y, Lin L, Zhang PF, Zou W, Saxe JP & Huang J (2003) Novel functions of the phosphatidylinositol metabolic pathway discovered by a chemical genomics screen with wortmannin. P Natl Acad Sci USA 100: 3345-3350.